Dr. Sarah Hartz is Assistant Professor of Psychiatry at Washington University in St. Louis, MO. Dr. Hartz holds a PhD in Statistics from the University of Illinois Urbana-Champaign (2003), and she performed her residency in Psychiatry at the University of Iowa Hospitals and Clinics and Washington University/Barnes-Jewish Hospital (2005-2009). Dr. Hartz is currently a physician scientist who has combined her background in statistics and genetics with her psychiatric training to better understand the genetics of substance dependence. Dr. Hartz's current research interests include 1) genetics of comorbidity between substance use disorders and other severe mental illness, 2) return of genetic results to research participants, and 3) application of quantitative methodologies to addiction genetics.
Recent Publications
- Mintz, CM, Knox, J, Hartz, SM, Hasin, DS, Martins, SS, Kranzler, HR, Greene, E, Geng, EH, Grucza, RA, Bierut, LJ et al.. Demographic differences in the cascade of care for unhealthy alcohol use: A cross-sectional analysis of data from the 2015-2019 National Survey on Drug Use and Health. Alcohol Clin Exp Res (Hoboken) 2023; 47 (10): 1890-1903. PubMed PMID:37864538 PubMed Central PMC10590988.
- Hartz, SM, Culverhouse, RC, Mintz, CM, Ellis, MS, Kasper, ZA, Cavazos-Rehg, P, Grucza, RA, Bierut, LJ, Cicero, TJ. Association between recent overdose and chronic pain among individuals in treatment for opioid use disorder. PLoS One 2022; 17 (11): e0271379. PubMed PMID:36441691 PubMed Central PMC9704550.
- Hartz, SM, Mozersky, J, Schindler, SE, Linnenbringer, E, Wang, J, Gordon, BA, Raji, CA, Moulder, KL, West, T, Benzinger, TLS et al.. A flexible modeling approach for biomarker-based computation of absolute risk of Alzheimer's disease dementia. Alzheimers Dement 2023; 19 (4): 1452-1465. PubMed PMID:36178120 PubMed Central PMC10060442.
- Mintz, CM, Xu, KY, Presnall, NJ, Hartz, SM, Levin, FR, Scherrer, JF, Bierut, LJ, Grucza, RA. Analysis of Stimulant Prescriptions and Drug-Related Poisoning Risk Among Persons Receiving Buprenorphine Treatment for Opioid Use Disorder. JAMA Netw Open 2022; 5 (5): e2211634. PubMed PMID:35544135 PubMed Central PMC9096599.
- Parsley, IC, Dale, AM, Fisher, SL, Mintz, CM, Hartz, SM, Evanoff, BA, Bierut, LJ. Association Between Workplace Absenteeism and Alcohol Use Disorder From the National Survey on Drug Use and Health, 2015-2019. JAMA Netw Open 2022; 5 (3): e222954. PubMed PMID:35297970 PubMed Central PMC8931561.
- Mintz, CM, Presnall, NJ, Xu, KY, Hartz, SM, Sahrmann, JM, Bierut, LJ, Grucza, RA. An examination between treatment type and treatment retention in persons with opioid and co-occurring alcohol use disorders. Drug Alcohol Depend 2021; 226 : 108886. PubMed PMID:34245997 PubMed Central PMC8370094.
- Mintz, CM, Hartz, SM, Fisher, SL, Ramsey, AT, Geng, EH, Grucza, RA, Bierut, LJ. A cascade of care for alcohol use disorder: Using 2015-2019 National Survey on Drug Use and Health data to identify gaps in past 12-month care. Alcohol Clin Exp Res 2021; 45 (6): 1276-1286. PubMed PMID:33993541 PubMed Central PMC8254783.
- Bray, MJ, Chen, LS, Fox, L, Ma, Y, Grucza, RA, Hartz, SM, Culverhouse, RC, Saccone, NL, Hancock, DB, Johnson, EO et al.. Studying the Utility of Using Genetics to Predict Smoking-Related Outcomes in a Population-Based Study and a Selected Cohort. Nicotine Tob Res 2021; 23 (12): 2110-2116. PubMed PMID:33991188 PubMed Central PMC8570670.
- Xu, KY, Borodovsky, JT, Presnall, N, Mintz, CM, Hartz, SM, Bierut, LJ, Grucza, RA. Association Between Benzodiazepine or Z-Drug Prescriptions and Drug-Related Poisonings Among Patients Receiving Buprenorphine Maintenance: A Case-Crossover Analysis. Am J Psychiatry 2021; 178 (7): 651-659. PubMed PMID:33653119 PubMed Central PMC8286284.
- Rahman, T, Patrick, C, Ma, C, Nicol, GE, Reynolds, CF 3rd, Mulsant, BH, Hartz, SM, Yingling, M, Lenze, EJ. Prolactin and Estrogen Levels in Postmenopausal Women Receiving Aripiprazole Augmentation Treatment for Depression. J Clin Psychopharmacol ; 41 (1): 31-35. PubMed PMID:33347020 .
The Hartz Lab Website
